Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Gutkin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Delivery|June 14, 2016
Harnessing nanomedicine for therapeutic intervention in glioblastomaAnna Gutkin, Zvi R Cohen, Dan Peer
Advanced Drug Delivery Reviews|July 14, 2020
Progress and challenges towards CRISPR/Cas clinical translationDaniel Rosenblum, Anna Gutkin, Niels Dammes, et al.
Harefuah|December 4, 2017
[EXOSOMES AS MEDIATORS OF INTERCELLULAR COMMUNICATION: THE CANCER AND TELOMERASE CONNECTION]Orit Uziel, Anna Gutkin, Einat Beery, et al.
Journal of Drug Targeting|October 9, 2018
Targeting central nervous system pathologies with nanomedicinesShoshy Mizrahy, Anna Gutkin, Paolo Decuzzi, et al.
Oncotarget|July 8, 2016
Tumor cells derived exosomes contain hTERT mRNA and transform nonmalignant fibroblasts into telomerase positive cellsAnna Gutkin, Orit Uziel, Einat Beery, et al.
British Journal of Cancer|June 23, 2017
Characterisation of blood-derived exosomal hTERT mRNA secretion in cancer patients: a potential pan-cancer markerHadar Goldvaser, Anna Gutkin, Einat Beery, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 25, 2021
Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticlesLiyona Kampel, Meir Goldsmith, Srinivas Ramishetti, et al.
Science Advances|November 19, 2020
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapyDaniel Rosenblum, Anna Gutkin, Ranit Kedmi, et al.
Biomedicines|June 28, 2023
Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to TherapyOfer Rotem, Alona Zer, Lilach Yosef, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 9, 2025
Low-frequency ultrasound-mediated blood-brain barrier opening enables non-invasive lipid nanoparticle RNA delivery to glioblastomaMaya Shumer-Elbaz, Nitay Ad-El, Yulia Chulanova, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Delivery|June 14, 2016
Harnessing nanomedicine for therapeutic intervention in glioblastomaAnna Gutkin, Zvi R Cohen, Dan Peer
Advanced Drug Delivery Reviews|July 14, 2020
Progress and challenges towards CRISPR/Cas clinical translationDaniel Rosenblum, Anna Gutkin, Niels Dammes, et al.
Harefuah|December 4, 2017
[EXOSOMES AS MEDIATORS OF INTERCELLULAR COMMUNICATION: THE CANCER AND TELOMERASE CONNECTION]Orit Uziel, Anna Gutkin, Einat Beery, et al.
Journal of Drug Targeting|October 9, 2018
Targeting central nervous system pathologies with nanomedicinesShoshy Mizrahy, Anna Gutkin, Paolo Decuzzi, et al.
Oncotarget|July 8, 2016
Tumor cells derived exosomes contain hTERT mRNA and transform nonmalignant fibroblasts into telomerase positive cellsAnna Gutkin, Orit Uziel, Einat Beery, et al.
British Journal of Cancer|June 23, 2017
Characterisation of blood-derived exosomal hTERT mRNA secretion in cancer patients: a potential pan-cancer markerHadar Goldvaser, Anna Gutkin, Einat Beery, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 25, 2021
Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticlesLiyona Kampel, Meir Goldsmith, Srinivas Ramishetti, et al.
Science Advances|November 19, 2020
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapyDaniel Rosenblum, Anna Gutkin, Ranit Kedmi, et al.
Biomedicines|June 28, 2023
Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to TherapyOfer Rotem, Alona Zer, Lilach Yosef, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 9, 2025
Low-frequency ultrasound-mediated blood-brain barrier opening enables non-invasive lipid nanoparticle RNA delivery to glioblastomaMaya Shumer-Elbaz, Nitay Ad-El, Yulia Chulanova, et al.
Pageof 1